NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1994
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 30m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Iobenguane Sulfate I-131 is a radioiodinated diagnostic and therapeutic agent used for imaging and treatment of neuroendocrine tumors, particularly pheochromocytoma and paraganglioma. It localizes to catecholamine-producing tissues and delivers targeted radiation therapy. The compound combines diagnostic imaging capability with therapeutic radionuclide delivery in a single agent.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating potential for team contraction or strategic repositioning initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Iobenguane I-131 positions professionals in a specialty oncology/endocrinology niche with deep expertise in radiopharmaceutical commercialization and rare disease patient management. The LOE-approaching lifecycle means career growth depends on strategy pivot—either defending market share or supporting transition planning.
Brand ManagerMedical Science Liaison
Worked on IOBENGUANE SULFATE I 131 at PharmaLundensis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.